On Friday, Mural Oncology plc (NASDAQ: MURA) opened lower -12.59% from the last session, before settling in for the closing price of $1.35. Price fluctuations for MURA have ranged from $1.28 to $5.12 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.55% over the past five years. Company’s average yearly earnings per share was noted 36.39% at the time writing. With a float of $15.34 million, this company’s outstanding shares have now reached $17.10 million.
Let’s look at the performance matrix of the company that is accounted for 116 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mural Oncology plc (MURA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mural Oncology plc is 10.97%, while institutional ownership is 52.81%. The most recent insider transaction that took place on Mar 04 ’25, was worth 14,491. Before that another transaction happened on Mar 05 ’25, when Company’s insider sold 1,469 for $3.45, making the entire transaction worth $5,068. This insider now owns 73,564 shares in total.
Mural Oncology plc (MURA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.51 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.39% per share during the next fiscal year.
Mural Oncology plc (NASDAQ: MURA) Trading Performance Indicators
Check out the current performance indicators for Mural Oncology plc (MURA). In the past quarter, the stock posted a quick ratio of 5.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.58, a number that is poised to hit -1.80 in the next quarter and is forecasted to reach -3.04 in one year’s time.
Technical Analysis of Mural Oncology plc (MURA)
Mural Oncology plc (NASDAQ: MURA) saw its 5-day average volume 1.36 million, a positive change from its year-to-date volume of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 1.70%. Additionally, its Average True Range was 0.37.
During the past 100 days, Mural Oncology plc’s (MURA) raw stochastic average was set at 1.66%, which indicates a significant decrease from 1.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 392.39% in the past 14 days, which was higher than the 162.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.7056, while its 200-day Moving Average is $3.4680. Nevertheless, the first resistance level for the watch stands at $1.3000 in the near term. At $1.4200, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5100. If the price goes on to break the first support level at $1.0900, it is likely to go to the next support level at $1.0000. The third support level lies at $0.8800 if the price breaches the second support level.
Mural Oncology plc (NASDAQ: MURA) Key Stats
There are currently 17,228K shares outstanding in the company with a market cap of 20.33 million. Presently, the company’s annual sales total 0 K according to its annual income of -128,510 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -34,270 K.
